People · Operator

Greg R. Colip

Named in public records as an officer, director or promoter · active 2008–2010 · Biotechnology

1
Companies
12
Filings
$57.5M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Cell Point, LLCBiotechnologySeries B$57.5M$99.9M2008
Operator network

Greg R. Colip at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Jerry Bryant · 4 companies · 1 sharedJerry BryantF. David A. Rollo · 1 companies · 1 sharedF. David A. RolloF. David Rollo · 1 companies · 1 sharedF. David RolloFrank David Rollo · 1 companies · 1 sharedFrank David RolloGreg Colip · 1 companies · 1 sharedGreg ColipGreg Russel Colip · 1 companies · 1 sharedGreg Russel ColipGreg Russell Colip · 1 companies · 1 sharedGreg Russell ColipJerry A. Bryant, Jr. · 1 companies · 1 sharedJerry A. Bryant, …Jerry Bryant, Jr. · 1 companies · 1 sharedJerry Bryant, Jr.Jerry Russel Bryant · 1 companies · 1 sharedJerry Russel Brya…Jerry Russell Bryant · 1 companies · 1 sharedJerry Russell Bry…Terry A. Colip · 1 companies · 1 sharedTerry A. ColipTerry Allen Colip · 1 companies · 1 sharedTerry Allen ColipTerry Colip · 1 companies · 1 sharedTerry ColipCell Point, LLC · $57.5M raisedCell Point, LLCGreg R. ColipGC
Greg R. Colip Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Greg R. Colip on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Jerry Bryant14
Terry Allen Colip11
Jerry Russell Bryant11
Greg Russell Colip11
Greg Russel Colip11
Jerry Russel Bryant11
Jerry Bryant, Jr.11
F. David Rollo11
Terry A. Colip11
Jerry A. Bryant, Jr.11
F. David A. Rollo11
Greg Colip11
Frank David Rollo11
Terry Colip11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.